SYSTEMIC DELIVERY OF A TUMOR-TARGETED TLR9 AGONIST CONJUGATE TRANSFORMS THE TUMOR IMMUNE LANDSCAPE AND INDUCES TUMOR REGRESSION IN MICE Candidate, C., Sagiv-Barfi, I., Neuhoefer, P., Czerwinski, D., Artandi, S., Bertozzi, C., Levy, R., Cochran, J. BMJ PUBLISHING GROUP. 2021: A803

View details for DOI 10.1136/jitc-2021-SITC2021.768

View details for Web of Science ID 000774877500739